Direct-acting antiviral hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - academic.oup.com
Background People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …
被引用次数：14 相关文章

Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …

Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV.

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - europepmc.org
Background People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …
[HTML] nih.gov

[HTML][HTML] Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Background People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …

Direct-acting antiviral hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV.

DF Haley, A Edmonds, C Ramirez, AL French, P Tien… - 2021 - cabidigitallibrary.org
Background: People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …
[PDF] core.ac.uk

[PDF][PDF] Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV

DF Haley, A Edmonds, C Ramirez, AL French… - The Journal of …, 2021 - core.ac.uk
Background. People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liverrelated mortality. Direct-acting antivirals (DAAs) yield high …

Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation among US Men and Women with and without HIV

DF Haley, A Edmonds, C Ramirez… - Journal of Infectious …, 2021 - cdr.lib.unc.edu
Background: People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …

Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - academic.oup.com
Background People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …

Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation among US Men and Women with and without HIV

DF Haley, A Edmonds, C Ramirez… - Journal of Infectious …, 2021 - pure.johnshopkins.edu
Background: People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liver-related mortality. Direct-acting antivirals (DAAs) yield high …
[PDF] academia.edu

[PDF][PDF] Direct-Acting Antiviral Hepatitis C Treatment Cascade and Barriers to Treatment Initiation Among US Men and Women With and Without HIV

DF Haley, A Edmonds, C Ramirez… - The Journal of …, 2021 - academia.edu
Background. People with HIV are disproportionately coinfected with hepatitis C virus (HCV)
and experience accelerated liverrelated mortality. Direct-acting antivirals (DAAs) yield high …